Background. Radiofrequency ablation (RFA) is a minimally invasive technique that can eradicate malignant disease in the liver, including metastatic disease from gynecological primary tumors. Case. An 81-year-old female underwent percutaneous RFA for a solitary intrahepatic metastatic lesion that was her only known site of disease 2 years after definitive surgery and chemotherapy for stage IIIC ovarian adenocarcinoma. She was able to start systemic chemotherapy 1 week after RFA, and continues to be free of disease in the liver. Conclusion. RFA can be a useful tool for treating liver tumors in patients who would otherwise not be candidates for liver resection. Its advantages include minimal invasiveness, low morbidity, and rapid recovery for expeditious treatment with systemic chemotherapy. © 2004 Elsevier Inc. All rights reserved.
CITATION STYLE
Bojalian, M. O., Machado, G. R., Swensen, R., & Reeves, M. E. (2004). Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: Case report and literature review. Gynecologic Oncology, 93(2), 557–560. https://doi.org/10.1016/j.ygyno.2004.01.041
Mendeley helps you to discover research relevant for your work.